Dr Chan Phetsouphanh – Immune dysfunction persists following mild-to-moderate SARS-CoV-2 infection

Event date
Tuesday 15th February 2022
Event time
1:00 PM
Event address
Online event



Online event
Please click on the link just before the start of the webinar




Contact for enquiries 

Rata Joseph, +61 (2) 9385 0900 or info@kirby.unsw.edu.au



A proportion of patients surviving acute COVID-19 infection develop post-COVID syndrome (long COVID) encompassing physical and neuropsychiatric symptoms lasting longer than 12 weeks. The underlying pathophysiology of long COVID is poorly understood and there is currently little evidence defining the mechanisms of systemic inflammation following COVID-19 and any immune correlates of ongoing symptoms. Here, I describe a prospective cohort of individuals followed systematically post confirmed COVID-19 infection (the ADAPT study) and compared them to healthy donors and individuals contemporaneously infected with other non-SARS-CoV-2 human coronaviruses (ADAPT-C) to firstly characterise their immunological features up to 8 months post COVID-19 infection and secondly to compare those with and without persisting symptoms at this time point. 


Dr Chan Phetsouphanh  

Dr Chan Phetsouphanh
Senior Research Associate, Immunovirology and Pathogenesis Program, Kirby Institute

Chan Phetsouphanh recently returned to the Kirby Institute from his postdoctoral position at the University of Oxford (UK). His projects involve the investigation of T cell responses during SARS-CoV-2 infection and evaluating immune signatures of long COVID. He has keen interests in T cell biology, infectious diseases, virally driven cancers and immunopeptidomics.


Opinions expressed in the Kirby Institute Seminar Series are solely those of the speaker and do not necessarily represent the views or opinions of the Kirby Institute or UNSW.